Ashley Hall serves as Executive at Esperion Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Ashley Hall has executed 6 insider transactions totaling $98.1K, demonstrating a bearish approach to their equity position. Their most recent transaction on Sep 18, 2025 involved selling 6,021 shares valued at $46.6K.
Ashley Hall currently holds 112,317 shares of Esperion Therapeutics, Inc. (ESPR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Ashley Hall has been a net seller of ESPR stock. They have purchased $0 and sold $98.1K worth of shares.
Ashley Hall's most recent insider trade was on Sep 18, 2025, when they sold 6,021 shares at $7.74 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Aug 28, 2023 | RPHM | $28.1K | Option Exercise | 15,625 | $1.80 | Discretionary |
| Aug 28, 2023 | RPHM | $98.1K | Sale | 15,625 | $6.28 | Discretionary |
| Nov 12, 2021 | RPHM | $0 | Award | 30,000 | $N/A | Discretionary |
| Jan 28, 2021 | ESPR | $0 | Award | 7,000 | $N/A | Discretionary |